Navigation Links
New Drug Combination is Able to Eradicate Breast Metastases in Mice
Date:12/17/2007

SAN ANTONIO, Dec. 17 /PRNewswire/ -- A novel combination of drugs was able to completely eradicate human breast metastases growing in mice, and shows promise for the effective treatment of patients with advanced metastatic breast cancer. Dr. Sophia Ran from Southern Illinois University School of Medicine presented the results of a study using nab-paclitaxel and bevacizumab to treat lymphatic and pulmonary metastases in female SCID mice.

Paclitaxel is a widely used cancer chemotherapy drug, originally derived from an extract of the yew tree. It can have severe side effects, some of which are related to the fact that it will not dissolve in water and has to be dissolved in organic solvents for injection. Nab-paclitaxel is a nanoparticle form of paclitaxel that is coated with a nonreactive protein, albumin, allowing it to be dissolved in water. This has reduced the side effects of the treatment, and also makes it more effective.

Bevacizumab is a monoclonal antibody against vascular endothelial growth factor A (VEGF-A), a protein that is involved in building new blood vessels. Tumors require new networks of blood vessels in order to grow.

The idea for this research came from the observation that, nf cells that survive treatment with chemotherapy, the stress of the treatment causes excess VEGF-A to be produced. The VEGF-A protects the cells against future chemotherapy, and also generates new blood vessels. Both mechanisms may contribute to tumor recurrence and metastatic spread following chemotherapy. This is the molecular basis for combining bevacizumab with nab-paclitaxel for the treatment of metastatic tumors.

For this study, human breast cancer cells were implanted into mammary fat pads (the mouse equivalent of breast tissue) of female mice. The implanted cells grew into tumors, and lymphatic and pulmonary metastases developed by the time that the drugs were administered.

The drug combination completely eradicated the origina
'/>"/>

SOURCE San Antonio Breast Cancer Symposium
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
4. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
5. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
6. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
7. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
8. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
9. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
10. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
11. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014  Halozyme Therapeutics, Inc. (NASDAQ: ... and Drug Administration (FDA) has removed the clinical ... in SWOG,s ongoing Phase 1b/2 clinical trial (S1313). ... drug PEGPH20 (PEGylated Recombinant Human Hyaluronidase) in combination ... metastatic pancreatic adenocarcinoma.  The study will resume under ...
(Date:9/18/2014)... , Sept. 18, 2014 Veterinary biologic ... Dr. Ashraf Hanna , M.D., Ph.D., and Dr. ... of Directors. Dr. Hanna is the Vice President of ... Financial Officer for the Genentech Foundation, while Dr. McCracken ... of Business Development and Licensing for Roche Pharma. ...
(Date:9/18/2014)... , Sept. 18, 2014 Australian biomarker discovery ... US trial of its MiStat™ prostate cancer screening test, ... regulatory approval upon completion. Minomic,s proprietary MiStat™ ... presence of a proprietary biomarker known as the MIL-38 ... prostate cancer cells. Researchers at 11 ...
Breaking Medicine Technology:SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2
... , NEW BRUNSWICK, N.J., Nov. 12 Senesco ... SNT ) announced today that Catherine Taylor, ... presenting pre-clinical stability and biological activity data on ... 2009 American Association for Cancer Research (AACR)-National Cancer ...
... Thoratec Corporation (Nasdaq: THOR ), a world leader ... and restore failing hearts, said today that it will ... HeartMate II Destination Therapy clinical trial that will be ... the American Heart Association(AHA) Scientific Sessions 2009. , The ...
Cached Medicine Technology:Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference 2Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference 3
(Date:9/18/2014)... Technology Association of Georgia in collaboration with ... Social Savvy Awards this week at a special ceremony ... in Downtown Atlanta. The event celebrates Georgia’s best and ... honored with the 2014 TAG Social Savvy People’s Choice ... in 6 other award categories: , , ...
(Date:9/18/2014)... (HealthDay News) -- Teens and young adults who,ve been ... that provides them with greater responsibility and independence early ... "We found that having a mentor provides a ... lead author, Steve McDonald, an associate professor of sociology ... news release. In conducting the study, published ...
(Date:9/18/2014)... Research led by Paulo Rodriguez, PhD, an assistant ... Health New Orleans, Stanley S. Scott Cancer Center, has ... Chop plays in the body,s ability to fight cancer. ... the activity and accumulation of cells that suppress the ... Orleans research team showed that when they removed Chop, ...
(Date:9/18/2014)... The Spartan race is known as ... course lengths of 3+miles (Sprint), 8+miles, (Super) and 12+miles ... signature obstacles designed to help participants discover their inner ... a Spartan Race and the feeling of accomplishment that ... and accept people of all ages, backgrounds, and fitness ...
(Date:9/18/2014)... September 18, 2014 Activz ... to announce the release of Activz Coconut Water ... liquid of young, organic coconuts from Thailand. Activz Coconut ... Activz Whole-Food Nutrition revolutionary line of produce powders available ... options. The new Activz Coconut Water Powder will ...
Breaking Medicine News(10 mins):Health News:Winners Honored at 2014 TAG Social Savvy Awards 2Health News:Winners Honored at 2014 TAG Social Savvy Awards 3Health News: Mentors May Steer Young People Toward More Rewarding Careers 2Health News:LSU Health research discovers means to free immune system to destroy cancer 2Health News:A Marine Corps Combat Veteran Teams Up with Spartan Races to Ease the Pain and Speed Up Recovery of Spartan Race Warriors with Topricin Pain Relief and Healing Creams 2Health News:A Marine Corps Combat Veteran Teams Up with Spartan Races to Ease the Pain and Speed Up Recovery of Spartan Race Warriors with Topricin Pain Relief and Healing Creams 3Health News:A Marine Corps Combat Veteran Teams Up with Spartan Races to Ease the Pain and Speed Up Recovery of Spartan Race Warriors with Topricin Pain Relief and Healing Creams 4Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 2Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 3
... BRANFORD, Conn., Sept. 5 CuraGen Corporation,(Nasdaq: CRGN ... that Dr. Frank M. Armstrong, President and Chief,Executive Officer, ... Bear,Stearns 20th Annual Healthcare Conference on Tuesday, September 11, ... held at The Grand Hyatt,New York in New York ...
... Va., Sept. 5 Traditional Latin,American foods have a ... foods that have brought families together for generations are,being ... Oftentimes Latin foods are prepared with high-calorie ingredients ... to the American Diabetes,Association (ADA), eating foods high in ...
... the Canadian Institutes of Health Research (CIHR) unveiled a ... of research it has funded. CIHR will require its ... freely available online within six months of publication. ... is a defining feature of science, and is essential ...
... PHOENIX, Sept. 4 TriWest Healthcare Alliance is,offering an ... have lost a loved one in service to our ... unit commanders, TriWest is partnering,with noted author and nationally ... killed in the line of duty. Through a ...
... MINNEAPOLIS, Sept. 4 HEI, Inc. (Nasdaq: HEII,-- ... closed on the sale of,substantially all of the ... Inc., a wholly-owned subsidiary of Dutch based Smartrac ... substantially all the assets of the,RFID division, including ...
... Brings Over 20 Years Of Experience ... in Sales, Marketing And Operational Excellence, LENEXA, Kan., ... ) announced the appointment of Thomas Kelly,Mann as chief ... than 20 years with 3M,s healthcare information technology,division where ...
Cached Medicine News:Health News:CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference 2Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 2Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 3Health News:Open access to health research publications 2Health News:TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program 2Health News:HEI, Inc. Closes on Sale of RFID Division Assets 2Health News:Mediware Names Thomas K. Mann Chief Executive Officer 2
Stainless steel flexible ruler. graduated in 1/32 inches (.8 mm) fractions, as well as mm graduations....
Designed to determine the precise length of limbal incisions and proper alignment of closing sutures. Curved marking blade with 2 mm lines spaced 1 mm apart-measures up to 10 mm. Round knurled handle...
Measures up to 152 mm in 1 mm increments and 6 inches in 1/32 inch increments. Deeply etched graduations and dull finish....
Rigid Endoscopes....
Medicine Products: